learning objectives
1. list three anticipated changes to the ATP IV guidelines
2. Compare and contrast two validated risk assessment tools used to stratify of developing cardiovascular disease and individualize LDL-c goals
3. Describe the primary treatment targets from the ATP III guidelines and potential changes for ATP IV